CAS: 1020172-07-9 - Rebastinib
Fórmula:C30H28FN7O3
- Sinónimos:
- N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea
- Dcc-2036
2-Pyridinecarboxamide, 4-[4-[[[[3-(1,1-dimethylethyl)-1-(6-quinolinyl)-1H-pyrazol-5-yl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-
CAS:1020172-07-9
Fórmula:
C30H28FN7O3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
553.5868
Ref: AN-AG0006BU
5mg | 67,00 € | |
10mg | 88,00 € | |
50mg | 168,00 € | |
100mg | 283,00 € | |
250mg | 636,00 € |
Entrega estimada en Estados Unidos, el Viernes 3 de Mayo de 2024
Rebastinib
CAS:1020172-07-9
DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and …
Fórmula:
C30H28FN7O3
Pureza:
99.84%
Forma y color:
Solid
Peso molecular:
553.59
Ref: TM-T2640
2mg | 47,00 € | |
5mg | 68,00 € | |
10mg | 94,00 € | |
25mg | 169,00 € | |
50mg | 247,00 € | |
100mg | 370,00 € | |
200mg | 557,00 € | |
1ml*10 (DMSO) | 83,00 € |
Entrega estimada en Estados Unidos, el Viernes 10 de Mayo de 2024
DCC 2036
CAS:1020172-07-9
Inhibits multiple tyrosine kinases (Abl1, Src family kinases, Tie-2 and VEGFR-2)
Fórmula:
C30H28FN7O3
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
553.59 g/mol
Ref: 3D-FD64998
10mg | 107,00 € | |
50mg | 330,00 € | |
100mg | 496,00 € | |
250mg | 789,00 € | |
500mg | 1.053,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Mayo de 2024
Rebastinib
CAS:1020172-07-9
Applications Rebastinib shows the selectivity for growth inhibition of Bcr-Abl-positive cells by its marked inhibition …
Fórmula:
C30H28FN7O3
Forma y color:
Off-White Solid
Peso molecular:
553.59
Ref: TR-R139300
1mg | 237,00 € | |
10mg | 707,00 € | |
2500µg | 517,00 € |
Entrega estimada en Estados Unidos, el Jueves 13 de Junio de 2024